Related references
Note: Only part of the references are listed.Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer
Basil Hassouneh et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Biomarkers for monitoring antiangiogenic therapy
Rupal S. Bhatt et al.
CLINICAL CANCER RESEARCH (2007)
Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1
Jose C. Juarez et al.
CLINICAL CANCER RESEARCH (2006)
Heparin-released extracellular superoxide dismutase is reduced in patients with coronary artery atherosclerosis
Hiromi Tasaki et al.
ATHEROSCLEROSIS (2006)
Angiogenesis as a therapeutic target
N Ferrara et al.
NATURE (2005)
Angiogenesis in life, disease and medicine
P Carmeliet
NATURE (2005)
Extracellular superoxide dismutase
E Nozik-Grayck et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Ceruloplasmin in neurodegenerative diseases
V Vassiliev et al.
BRAIN RESEARCH REVIEWS (2005)
Serum superoxide dismutase 3 (extracellular superoxide dismutase) activity is a sensitive indicator of Cu status in rats
WT Johnson et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2005)
Control of copper status for cancer therapy
VL Goodman et al.
CURRENT CANCER DRUG TARGETS (2005)
Circulating endothelial progenitor cells in multiple myeloma:: implications and significance
H Zhang et al.
BLOOD (2005)
Copper transport and metabolism are normal in aceruloplasminemic mice
LA Meyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)